https://www.avient.com/sites/default/files/2025-04/Corporate Governance Guidelines. March 2025 - Final and Approved version.pdf
Committees
The Board has an Audit Committee, a Compensation Committee, a Governance and
Corporate Responsibility Committee, and an Environmental, Health and Safety
Committee.
The Board administers its risk oversight function directly and through its committees.
8
The Board has delegated specific risk oversight responsibility to the committees of the
Board as follows: (i) the Audit Committee oversees risks related to the Company’s
financial statements, financial reporting processes, internal controls, information
technology, and cybersecurity; (ii) the Compensation Committee oversees risks related to
the Company’s compensation programs; (iii) the Governance and Corporate
Responsibility Committee oversees risks related to the Company’s programs, policies,
and practices related to certain sustainability and governance matters, including a review
of reports on corporate responsibility and/or sustainability published by the Company;
and (iv) the Environmental, Health and Safety Committee oversees risks related to safety,
health, physical security, environmental, and product stewardship matters.
The
Compensation Committee reviews market data for director compensation to ensure that
the Company’s director compensation is reasonable and competitive in relation to similar
companies.
https://www.avient.com/industries/consumer/consumer-staples/everyday-essentials/apparel-footwear-accessories
Dynaflex™ Thermoplastic Elastomers
https://www.avient.com/industries/packaging/beverage-packaging/rtd-teas-and-juices
Dynaflex™ Thermoplastic Elastomers
https://www.avient.com/industries/packaging/beverage-packaging/wine-and-spirits
Dynaflex™ Thermoplastic Elastomers
https://www.avient.com/industries/consumer/consumer-discretionary/home-household/home-improvement
Dynaflex™ Thermoplastic Elastomers
https://www.avient.com/industries/packaging/beverage-packaging/carbonateds
Dynaflex™ Thermoplastic Elastomers
https://www.avient.com/sites/default/files/2022-03/CESA Block Product Selector Guide.pdf
CESA™ Block Additives
Antiblocking
PRODUCT SELECTION GUIDE
Unmodified film and sheet can adhere, causing
problems of separation.
CESA™ Block additives
modify the surface characteristics and improve
the coefficient of the friction of the sheet or film,
preventing self-adhesion.
https://www.avient.com/sites/default/files/2020-10/light-diffusion-case-study.pdf
Despite
using an acrylic sheet with built-in light diffusion
technology, the light source was plagued by visual
“hot spots.”
Also,
the acrylic sheets required an additional process to
cut them to size before thermoforming, which led to
excessive waste and disposal costs.
Instead of purchasing pre-fabricated acrylic
sheet that contained a costly diffusion additive, the
Smartbatch solution enabled the customer to reduce its
material costs by 50%.
https://www.avient.com/sites/default/files/resources/Gabelli%2520Conf%2520-%2520POL%2520IR%2520Presentation%2520wNon%2520GAAP%2520Reconciliation%252003%252026%252015.pdf
S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 2015 Target
“Where we were” “Where we are” (Est. in 2012)
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.7% 12 – 16%
Global Specialty Engineered
Materials 1.1% 12.1% 12 – 16%
Designed Structures & Solutions 1.4% (2012) 7.3% 8 – 10%
Performance Products &
Solutions 5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 65% 65 – 75%
3) ROIC* 5.0% 11.3% 15%
4) Adjusted EPS Growth N/A 37% Double Digit
Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Proof of Performance & 2015 Goals
PolyOne Corporation Page 10
Continuing Earnings Growth
Double
Digit EPS
Expansion
Ongoing LSS
Programs
Incremental
Share
Buybacks
Mergers &
Acquisitions
Continued
Gross
Margin
Expansion
Mid Single
Digit
Revenue
Growth
Accelerated
Innovation &
Mix
Improvement
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
60%
94%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of December 31, 2014
Debt Maturities & Pension Funding – 12/31/14
Net Debt / EBITDA* = 1.9x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of December 31, 2014
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 12/31/2014
PolyOne Corporation Page 14
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
(including synergy
capture)
~75% of capital
expenditures fund
growth initiatives
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
• Operating Margin
Synergy opportunities
Adjacent material
solutions
Repurchased 1.6
million shares in Q4
2014
Repurchased 11.3
million shares since
early 2013
8.7 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 15
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 16
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Gabelli Conf - POL IR Presentation
��PolyOne Investor Presentation�Gabelli Specialty Chemicals Conference�March 2015��
Forward-Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
Proof of Performance & 2015 Goals
Continuing Earnings Growth
Innovation Drives Earnings Growth
Megatrends Aligned with Key End Markets
Debt Maturities & Pension Funding – 12/31/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
PolyOne Core Values
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
Strong past performance demonstrates that our
strategy and execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation
and competitive advantage
• Strong and proven management team driving
growth and performance
• Addressable market exceeds $40 billion
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Page 15
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9
Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7
Platform sales and operating income (OI) H1 2012*** H1 2013***
Global Specialty Engineered Materials Sales $ 280.9 $ 352.0
Global Color, Additives and Inks Sales 413.9 434.7
Designed Structures & Solutions Sales - 240.4
Specialty Platform Sales 694.8 1,027.1
Performance Products and Solutions Sales 336.0 336.7
PolyOne Distribution Sales 533.6 543.1
Corporate and Eliminations (62.3) (68.2)
Total Sales $ 1,502.1 $ 1,838.7
Global Specialty Engineered Materials OI $ 24.6 $ 32.5
Global Color, Additives and Inks OI 44.0 54.7
Designed Structures & Solutions OI - 10.5
Specialty Platform OI $ 68.6 $ 97.7
Performance Products and Solutions OI 19.3 27.5
PolyOne Distribution OI 33.4 33.1
Corporate and eliminations (20.3) (25.7)
Special items in OI (20.3) (11.4)
Operating income - GAAP $ 80.7 $ 121.2
Special items in OI 20.3 11.4
Operating income adjusted $ 101.0 $ 132.6
Global Specialty Engineered Materials - OI % of sales
8.8% 9.2%
Global Color, Additives and Inks - OI % of sales 10.6% 12.6%
Designed Structures & Solutions – OI % of sales - 4.4%
Specialty platform OI % of sales 9.9% 9.5%
PP&S operating OI % of sales 5.7% 8.2%
Distribution OI % of sales 6.3% 6.1%
PolyOne OI adjusted, % of sales 6.7% 7.2%
Reconciliation to Condensed Consolidated Balance Sheets H1 2013
Short-term debt and current portion of long-term debt $ 8.7
Long-term debt 1,022.5
Less cash and cash equivalents (392.4)
Specialty Platform Gross Margin Percentage 2006Y* Q2 2013****
Global Specialty Engineered Materials Sales $ 345.3 $ 143.5
Global Color, Additives and Inks Sales 531.8 207.5
Specialty Platform Sales $ 877.1 $ 351.0
Global Specialty Engineered Materials Gross Margin $ 41.6 37.3
Global Color, Additives and Inks Gross Margin 83.6 71.8
Specialty Platform Gross Margin $ 125.2 $ 109.1
Specialty Platform Gross Margin Percentage 14.3% 31.1%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
August 13 - Jefferies 2013 Investor Presentation non-GAAP v2 (2).pdf
Reconciliation to Condensed Consolidated Balance Sheets